… the current analysis was to evaluate the comparative efficacy of long-acting bronchodilators
in … Approved bronchodilators or those for which data was available at the time of the literature …

… systematic reviews on dual combination inhalers and long‐acting bronchodilators to
answer the questions described above using the strength of a network meta‐analysis (NMA). …

… The main findings of this systematic review and meta-analysis are: 1) long-acting
bronchodilators are effective in improving exercise capacity in COPD patients, with an average …

… ∼21 when compared to single long-acting bronchodilator therapy. The person-based NNT
per … This meta-analysis suggests that patients on single long-acting bronchodilator therapy or …

… a systematic review and meta-analyses to estimate the safety … -acting β-agonist/long-acting
muscarinic antagonist dual therapy or monotherapy with a single long-acting bronchodilator …

Full article: Relationship of inhaled long-acting bronchodilators with cardiovascular
outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 …

… In order to identify the totality of evidence for both the effectiveness and safety of inhaled
corticosteroids and long-acting bronchodilators within the context of ACO, we included both …

… ≈21 when compared to single long-acting bronchodilator therapy. The risk of pneumonia
did … This meta-analysis suggests that patients on single long-acting bronchodilator therapy or …

… acting bronchodilators (ILABs), such as long-acting muscarinic antagonists (LAMAs) and
long-acting … The current meta-analysis aimed to investigate the correlation of ILABs with specific …

… By examining steroids and bronchodilators in a single systematic review and supplementing
the standard meta-analysis with mixed treatment comparisons, this review provides some …